Clinical Trial Update: 129Xe MRI in Pediatric Population With BPD [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating 129Xe MRI in pediatric patients with Bronchopulmonary Dysplasia has been withdrawn. No results are reported due to withdrawal.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia

Snippet

Sponsor: Xemed LLC | Conditions: Bronchopulmonary Dysplasia | Phase 1 | Status: WITHDRAWN